BMO Capital Raises PT on Cameco Corporation (CCJ) to $86.72, Maintains ‘Outperform’ Rating

Cameco Corporation (NYSE:CCJ) is one of the 12 Best Uranium Stocks to Buy Right Now.

BMO Capital Raises PT on Cameco Corporation (CCJ) to $86.72, Maintains ‘Outperform’ Rating

On August 29, 2025, BMO Capital raised its price target on Cameco Corporation (NYSE:CCJ) from $79.49 to $86.72, maintaining an ‘Outperform’ rating. This price revision comes despite the company’s warning of a 19% production cut at McArthur River. While the impact on EBITDA is projected to be less significant, higher third-party U3O8 purchases could reduce free cash flow by 5%.

At the same time, the investment firm emphasized that the deepening uranium supply deficit, which is expected to result in stronger prices ahead of the World Nuclear Symposium, can spark fresh contracting activity, bolstering investor confidence in uranium producers, such as Cameco Corporation (NYSE:CCJ).

Cameco Corporation (NYSE:CCJ) is focused on exploration, mining, refining, conversion, and fabrication of uranium concentrate, serving global nuclear energy markets through its Uranium and Fuel Services segments. It is one of the best uranium stocks.

While we acknowledge the potential of CCJ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CCJ and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Unstoppable Canadian Stocks to Buy Now and 14 Best IT Stocks to Buy for the Long Term.

Disclosure: None.